Showing results (181-190 of 193) with videos related to
Sort By:
Pageof 20
The New England Journal of Medicine|December 21, 2007
Telbivudine versus lamivudine in patients with chronic hepatitis BChing-Lung Lai, Edward Gane, Yun-Fan Liaw, et al.The American Journal of Gastroenterology|September 23, 2003
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic statusAdrian M Di Bisceglie, Andre C Lyra, Myron Schwartz, et al.The New England Journal of Medicine|April 12, 2014
Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirinStefan Zeuzem, Ira M Jacobson, Tolga Baykal, et al.Journal of Viral Hepatitis|April 12, 2019
Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis BAdrian M Di Bisceglie, Wendy C King, Mauricio Lisker-Melman, et al.Hepatology (Baltimore, Md.)|April 27, 2011
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis CJules L Dienstag, Marc G Ghany, Timothy R Morgan, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2014
Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotypeMarc G Ghany, Robert Perrillo, Ruosha Li, et al.The American Journal of Gastroenterology|January 4, 2023
Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis BNorah A Terrault, Anna S Lok, Abdus S Wahed, et al.The New England Journal of Medicine|June 24, 2011
Telaprevir for previously untreated chronic hepatitis C virus infectionIra M Jacobson, John G McHutchison, Geoffrey Dusheiko, et al.Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.Journal of Autoimmunity|August 10, 2020
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug developmentArie Regev, Mark I Avigan, Alexandre Kiazand, et al.Pageof 20